HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness (Dietary Supplements)

Set Alert for Wellness

Regulation / Legislation Explore this Topic

Set Alert for Regulation and Legislation {Wellness}

Latest From Regulation & Wellness

US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

FDA Legislation

Potential For Industry To Have Greater Involvement In EFSA Consultations

EFSA-commissioned report proposes changes to the way the authority conducts consultations on its scientific assessments which could give industry more opportunities for involvement.

Europe Risk Management

NDAC Among US FDA Advisory Committees With Slot Open For Voting Consumer Representative

FDA asks for nominations for voting or non-voting consumer members of its advisory committees. Also wants to hear from consumer organizations interested in participating in selecting consumer representatives for its advisory committees or panels.

Advisory Committees Prescription To OTC Switch
See All

Latest From Legislation & Wellness

US FDA May See Second Straight Year of Non-User Fee Funding Cuts From Congress

The House Appropriations Agriculture, Rural Development, and FDA Subcommittee advanced the FDA’s fiscal year 2025 funding bill, beginning a likely long and difficult budget cycle. 

FDA Legislation

US FDA Reorganization Branches Out Supplement Industry Regulation, Adds Enforcement Unit

Finished product following Reagan-Udall food safety programs review establishes Human Foods Program in commissioner’s office while also realigning centers, offices and divisions across agency to improve collaboration with regulatory affairs, which conducts facility inspections and other field operations.

FDA Leadership

California Advances Legislation To Age-Restrict Sales Of Supplements, OTCs For Weight Loss

Senate committee amends bill to lower to $250 the largest civil penalty for violations; exempt retail clerks from “disciplinary action or discharge by the retail establishment” related to violations; and make changes to state’s Health and Safety Code effective in January 2026.

Dietary Supplements OTC Drugs
See All

Business Explore this Topic

Set Alert for Business {Wellness}

Latest From Deals & Wellness

CV Sciences Makes Move For Increased Softgel Capacity, Captek Launches Gummy Production

CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. Captek Softgel starts gummy supplement production at a 60,000-square foot facility.

Manufacturing Dietary Supplements

Valbiotis Seeking Launch Partner For Prediabetes Supplement After Nestlé Walks Away

Shifting priorities sees Nestlé Health Science drop a long-term collaboration with Valbiotis for the development and commercialization of a plant-based dietary supplement targeted at sufferers of prediabetes and type-2 diabetes.

Deals Dietary Supplements

Nestlé Joins Forces With Dr Reddy’s In India To Grow Dietary Supplements Reach

By teaming up with local player Dr Reddy's, Nestlé is hoping to improve the distribution and reach of dietary supplement brands like Nature's Bounty in India. The company announced its India joint venture as it reported Q1 sales down at its Health Science business.

India Dietary Supplements
See All

Latest From Business Strategies & Wellness

Alliance Pharma Books £46m Impairment Charge Related To US Menopause Supplement

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

Sales & Earnings Dietary Supplements

CV Sciences Makes Move For Increased Softgel Capacity, Captek Launches Gummy Production

CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. Captek Softgel starts gummy supplement production at a 60,000-square foot facility.

Manufacturing Dietary Supplements

People On The Move: Appointments At Arkopharma, PGEU, PLT

A round-up of the latest health and wellness industry moves: Arkopharma appoints chief executive officer, PGEU names leadership team for 2025; PLT Health hires China BD director.

Leadership Executive Changes
See All

Latest From Sales & Earnings & Wellness

Alliance Pharma Books £46m Impairment Charge Related To US Menopause Supplement

Alliance Pharma has been hit by a non-cash impairment charge of £46.4m related to its Amberen dietary supplement reflecting the brand's struggles in the US e-commerce market.

Sales & Earnings Dietary Supplements

Germany's PharmaSGP Continues To Outpace CHC Market Growth

Strong sales in Germany and Italy helped drive up PharmaSGP's consumer health product revenues by around a quarter in the opening three months of 2024.

Sales & Earnings Germany

Currency Headwinds Hold Back Recordati OTC In Q1

Headwinds for the Russian ruble and Turkish lira held back growth at Recordati's OTC business in the first quarter of 2024.

Europe Italy
See All

Latest From Legal Issues & Wellness

Ordinary Marketing Or Consumer Trap? Talking ‘Dark Patterns’ With Attorney Lauren Aronson

Whether called “dark patterns,” “shady” online marketing practices, or simply deception on the internet, the issue has taken on high importance at the US Federal Trade Commission and is being tackled by new laws in a growing number of states. Amin Talati Wasserman partner Lauren Aronson discusses in this interview with HBW Insight.

Legal Issues Advertising, Marketing & Sales

FTC Might Need More Illumination On Proposed Rule For Online Consumer Product Reviews

BBB National Programs found FTC’s proposed Trade Regulation Rule on the Use of Consumer Reviews and Testimonials largely effective with some certainty on whether product reviews or customer testimonials are violations of its false advertising standards. But it =expects some clarifications may come in final rule.

Ad Complaints Consumer

FTC Gives Stage To Critics And Champions Of Online Consumer Product Reviews, Testimonials

Speakers scheduled for hearing are Fake Review Watch, which says it’s “dedicated to exposing the massive corruption of online consumer review platforms”; University of California-Davis researchers who found widespread fraud; and Interactive Advertising Bureau, which says its members account for 86% of online advertising expenditures in the US.

E-Commerce Ad Complaints
See All

Marketing Explore this Topic

Set Alert for Marketing {Wellness}

Latest From Launches & Wellness

Stada Bringing Histamine Intolerance Supplement To US

Germany's Stada has its eyes on expansion in the US dietary supplements market with the launch of histamine intolerance line Histasolv.

Launches Dietary Supplements

Stabilizing Formula Business ‘First And Foremost’ For Perrigo To Reach Sustainable Growth

Perrigo’s adjusted operating income from formula business in 2023 was around half the $140m it expects. Level won’t be reached in 2024 but it’s “well on track to recapturing” that amount in 2025 and to “capturing all of that plus in 2026,” says CEO Patrick Lockwood-Taylor.

Business Strategies OTC Drugs

US Consumer Health Sector Seizing Opportunity To Market Products, Services To GLP-1 Patients

Latest moves on selling to consumers using GLP-1 receptor agonist drugs for obesity come from firms as large as global food products manufacturer and marketer Nestle and as small as startup Promino and as ambitious as men’s health product marketer Ro offering an app at no charge to find GLP-1 drugs.

Consumer Launches
See All

Latest From Ad Campaigns & Wellness

CARU Puts Brands On Notice: Guidelines For Children’s Advertising Extend To AI

The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.

US States Beauty

Herbalife Opens Direct Lines To President, Recalculates On Marketing To GLP-1 Patients

During recent investor conference, president Stephan Gratziani and CFO John DeSimone discuss Herbalife’s restructuring in addition to progress on digital transformation program and lack of progress on expectations for marketing to consumers prescribed GLP-1 drugs for weight loss.

Dietary Supplements Restructuring

US Wellness Market People News: NOW Expert Panel, WIN Awards, Promino Brand Ambassadors

NOW’s “curated collective of experts” for advice and wellness tips; Women In Nutraceuticals launches awards program; and Promino builds brrand ambassador roster.

Dietary Supplements Executive Changes
See All

Latest From Ad Complaints & Wellness

ASA Files: Denigrating Competitors ‘Isn’t A Good Look’ For Advertisers

Bayer Consumer Health and its effervescent vitamin brand Berocca were subjects of denigratory remarks by an online competitor in a recent UK advertising complaint ruling. The ASA’s Freddie Alcock talks HBW Insight through the complaint, explaining in this exclusive interview why denigration is never a good look for advertisers.

United Kingdom Health

ChromaDex Ordered To Pay Elysium’s Attorney Fees

“So lacking in substance that it ‘stands out’ from the dozens of [patent infringement] challenges I have encountered as a judge in the last five years,” says Colm Connolly, Delaware district chief judge. His ruling doesn’t end the firms’ litigation as related cases continue in federal courts in California and New York.

Dietary Supplements Litigation

Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims

“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.

Litigation Ad Complaints
See All
UsernamePublicRestriction

Register